Nijmegen Institute for Science Practitioners in Addiction (NISPA), Nijmegen, The Netherlands; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands
2Articles
5.2KReads1
2024–2026Active
32Collaborators
4Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Arnt Schellekens, MD, PhD, is affiliated with the Nijmegen Institute for Science Practitioners in Addiction (NISPA) and the Department of Psychiatry at Radboud University Medical Center in Nijmegen, The Netherlands. Schellekens has published research on addiction and attention-deficit/hyperactivity disorder, focusing on placebo effects in substance use disorders and treatment predictors in patients with comorbid ADHD and substance use disorders. Contributions include systematic reviews and cohort study results in these clinical areas. Schellekens frequently collaborates with Albert Batalla, Alex H. Abraham Begeman, Anil Thomas, Brian Johnson, and Christoffer Brynte.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
